This is a preview of subscription content, log in via an institution to check access.
References
NICE. NICE draft guidance recommends new tests to help rule-out pregnancy complication and avoid unnecessary hospital admissions. Media Release : 16 Dec 2015. Available from: URL: http://www.nice.org.uk
NICE. NICE recommends elosulfase alfa (Vimizim) for treatment of very rare life-limiting genetic disorder under managed access agreement. Media Release : 16 Dec 2015. Available from: URL: http://www.nice.org.uk
NICE. NICE issues guidance not recommending apremilast for psoriatic arthritis. Media Release : 16 Dec 2015. Available from: URL: http://www.nice.org.uk
NICE. Kadcyla price too high for routine NHS funding, says NICE in final guidance. Media Release : 16 Dec 2015. Available from: URL: http://www.nice.org.uk
NICE. NICE issues revised draft guidance on ezetimibe for hypercholesterolaemia. Media Release : 24 Dec 2015. Available from: URL: http://www.nice.org.uk
NICE. Further research needed on potential benefits of new allergy test, says NICE in draft guidance. Media Release : 11 Jan 2016. Available from: URL: http://www.nice.org.uk
Rights and permissions
About this article
Cite this article
Latest recommendations from NICE: some positive, et al. . .. PharmacoEcon Outcomes News 744, 35 (2016). https://doi.org/10.1007/s40274-016-2739-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-2739-4